BioMarin Pharma (BMRN) Posts Q4 Loss of $0.53
Tweet
Share
E-mail
Get Alerts BMRN Hot Sheet
Price: $64.63 --0%
Revenue Growth %: +32.7%
Financial Fact:
Interest expense: -9.98M
Today's EPS Names:
CULP, KFY, NNOX, More
Revenue Growth %: +32.7%
Financial Fact:
Interest expense: -9.98M
Today's EPS Names:
CULP, KFY, NNOX, More
Join SI Premium – FREE
BioMarin Pharma (NASDAQ: BMRN) reported Q4 EPS of ($0.53), which may not compare to the analyst estimate of ($0.38). Revenue for the quarter came in at $300 million versus the consensus estimate of $295.96 million.
For earnings history and earnings-related data on BioMarin Pharma (BMRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- Oracle (ORCL) Reiterated at Market Outperform by Citizens on Positive Due Diligence Results
- Braze, Inc. (BRZE) Tops Q2 EPS by 4c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
